Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03041623 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Japanese Idiopathic Interstitial Pneumonias Registry

Study acronym: JIPS
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 5, 2026 (before its estimated September 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Mar 2021 to Sep 2026
    • Study completion date: Mar 2025 to Mar 2027
    • Site details revised at 33 of 86 sites
    v8
  2. Study completion date: May 2023 to Mar 2025v7
  3. Study completion date: Mar 2021 to May 2023
    • Secondary endpoints: details revised at 4 of 7 entries
    v6
  4. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 800 to confirmed 867
    • Secondary endpoints: 6 to 7
    • Site details revised at 86 of 86 sites
    v5
  5. Secondary endpoints: 5 to 6v4
Show 2 earlier versionsHide 2 earlier versions
  1. Study sites: 83 to 86
    • Study description expanded, about 1 word
    v3
  2. Study sites: 23 to 83v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
An objective of JIPS Registry is to examine disease behavior of idiopathic interstitial pneumonias (IIPs), considering classification, background, and diagnostic methods based on American Thoracic Society (ATS)/ European Respiratory Society(ERS) /Japanese Respiratory Society (JRS)/ Latin American Thoracic Association (ALAT) guidelines for diagnosis and the ATS/ERS classification of 2002 and 2013.
Trial Details
NCT Number NCT03041623
Lead Sponsor North East Japan Study Group
Collaborators: Boehringer Ingelheim
Conditions
(from sponsor)		 Idiopathic Interstitial Pneumonia
Related terms Idiopathic Interstitial Pneumonias
Enrollment 867 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov